As of April 13, 2025, there is no verified information or official confirmation supporting any rumors surrounding the death or alleged suicide of Dr. Ralf P. Thomas, the Chief Financial Officer (CFO) of Siemens AG. He continues to actively fulfill his duties at the helm of the company’s financial operations. Dr. Thomas’s current term on the Managing Board was extended in December 2021 and remains in effect through December 14, 2026, as confirmed in Siemens’ publicly released corporate statement.
Dr. Thomas has been an integral part of Siemens for three decades, having joined the global technology powerhouse in 1995. Over the years, he has played a key role in shaping the company’s financial strategy, operational resilience, and long-term growth. He first rose through the ranks by taking on various leadership roles in finance, including serving as the CFO of Siemens’ Industry Sector and leading Corporate Finance functions such as Accounting, Controlling, Reporting, and Taxes. His appointment as CFO and member of the Managing Board in 2013 solidified his standing as a core figure in Siemens’ executive leadership team.
Dr. Thomas’s influence extends well beyond Siemens itself. He currently chairs the Supervisory Board of Siemens Healthineers AG, one of the world’s leading medical technology companies. His governance experience also includes serving on the Supervisory Board of Allianz Versicherungs-AG, a prominent insurance provider. In addition, he holds respected public service and scientific advisory roles—such as Chairman of the Stock Exchange Commission of Experts at Germany’s Federal Ministry of Finance, and as Treasurer and Administrative Board Member for the Max Planck Society for the Advancement of Science e.V., an organization globally renowned for its research and innovation.
Throughout his tenure, Dr. Thomas has guided Siemens through complex financial terrains, helping the company weather macroeconomic volatility, navigate geopolitical challenges, and adapt to shifting market dynamics. His leadership during times of uncertainty—particularly in markets affected by political tensions, such as the United States—has been marked by pragmatism and foresight. Under his financial guidance, Siemens reported a 5% year-over-year increase in net income for the fiscal year 2024, reaching a robust €8.99 billion—a clear indication of sustained performance and shareholder value.
In light of the current speculation circulating online, it is important to emphasize that Dr. Thomas remains a fully active and visible presence in his professional capacity. No credible sources have released any statements suggesting otherwise. Siemens AG has not issued any reports indicating a change in his status, and his professional activities continue in alignment with the company’s long-term strategic plans.
In short, Dr. Ralf P. Thomas continues to serve Siemens AG with distinction, reinforcing his reputation as one of Germany’s most seasoned financial executives. Any claims or assumptions to the contrary are entirely unfounded and should be treated with appropriate skepticism unless verified by official channels.
